Development of Neo Red Cells (NRC) with the enyzmatic reduction system of methemoglobin

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 4, 1997, Pages 417-427

  Ogata, Y ^a   Goto, H ^a   Kimura, T ^a   Fukui, H ^a  

^a TERUMO CORPORATION   (Japan)

Author keywords

Anemia; Blood substitutes; Liposome encapsulated hemoglobin; Liposome surface modification; Methemoglobin reduction system; Oxygen carrier

Indexed keywords

ARTIFICIAL ORGANS; BLOOD SUBSTITUTES; CHOLESTEROL; COENZYMES; ENCAPSULATION; GLUCOSE; HEMOGLOBIN; LIPIDS; LIVING SYSTEMS STUDIES; OXYGEN; SURFACE TREATMENT; TRANSPORT PROPERTIES;

METHEMOGLOBIN REDUCTION SYSTEM; NEO RED CELLS;

CELLS;

ADENINE; ALPHA TOCOPHEROL; BLOOD SUBSTITUTE; CHOLESTEROL; ENZYME; GLUCOSE; HEMOGLOBIN; INOSINE; LACTIC ACID; LIPOSOME; LIPOSOME ENCAPSULATED HEMOGLOBIN; MACROGOL; METHEMOGLOBIN; MYRISTIC ACID; NEO RED CELL; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHYTIC ACID; PYRUVIC ACID; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; CARDIOPULMONARY BYPASS; ENCAPSULATION; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL CIRCULATION; HYPOTHERMIA; OXYGEN TRANSPORT; REDUCTION; SAFETY;

ANIMALIA;

EID: 0031194235     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709118931     Document Type: Article

References (16)

1. O'Shaughnessy L., Mansell BM., Slome D. Hemoglobin solution as a blood substitute. Lancet 1939;2:1068-9
2. Amberson WR., Jennings JJ., Rhode CM. Clinical experience with hemoglobin-saline solutions. Appl Physiol 1949;1:469-89
3. Savisky Jp., Doczi J., Black J., Arnold JD. A clinical safety trial of stroma-free hemoglobin and its effect on tissue oxygenation. Bibl Anat 1977;15:375-9
4. Devenuto F. Hemoglobin sokutions as oxygen-delivering resuscitation fluids. Crit Care Med 1982;10:238-45
5. α2). J Biol Chem 1986;21:9929-37
6. Snyder SR., Welty EV., Walder RY., Williams LA., Walder JA. HbXL99α: a hemoglobin derivative that is cross-linked between the α subunits is useful as a blood substitute. Proc Natl Acad Sci USA 1987;84:7280-4
7. Przzybelski RJ., Malcolm DS., Burris DG., Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med ;1991:143-51
8. Parry, E. in Blood Substitutes: Preparation, Physiology and Medical Applications, ed. Lowe, K. C. 1988; 17-51
9. Greenburg, A. C. in Blood Substitutes, eds Chang, T. M. S. & Geyer, R. P. 1989;71-77
10. Olding -Smee, W. G. & Wilson, B. G. in Blood Substitutes: Preparation, Physiology and Medical Applications, ed. Lowe, K. C. 1988;71-86
11. Djordjevich L., Miller FI. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol 1980; 8: 584-92
12. Farmer MC., Gaber BP. Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system. Methods Enzymol 1897; 149: 184-200
13. Hunt CA., Burnette RR., MacGreor RD., et al. Synthesis and evaluation of a prototypal artificial red cell. Science 1985; 230: 1165-68
14. Hamasaki N. Quantitative estimation of preserved erythrocyte function. J. of Jap. Soc. of Blood Trans. 1985; 31(2); 103-9
15. Takahashl A. Characterization of Neo Red Cells (NRC), their function and safety in-vivo tests. Art. Cells, Blood Subs., And Immob. Biotech., 23(3), 347-354 (1995)
16. Cliff R.O., Liger F., Goins B., Hoffmann P.M., Spielberg H., Rudolph A.S Liposome encapsulated hemoglobin: long-term storage stability and in vivo characterization. Biomat. Art. Cells & Immob. Biotec. 1992; 20; 619-26